Name
Perearst Heiki Annuk OÜ
Registry code
12575421
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
26.11.2013 (10)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
86211 - Provision of general medical treatment
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Heiki Annuk 05.07.1969 (55) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
MTÜ Eesti Esmatasandi Tervisekeskuste Liit 80628250 | - | - | - | Founder (without contribution) |
2019 21.09.2020 | 2020 20.07.2022 | 2021 20.07.2022 | 2022 14.08.2023 | |
---|---|---|---|---|
Total Revenue | 132 394 € | 165 488 € | 202 112 € | 272 248 € |
Net profit (loss) for the period | -75 € | 1 842 € | 1 227 € | 846 € |
Profit Margin | -0% | 1% | 1% | 0% |
Current Assets | 18 976 € | 21 929 € | 17 711 € | 16 282 € |
Fixed Assets | 15 472 € | 16 688 € | 14 446 € | 18 156 € |
Total Assets | 34 448 € | 38 617 € | 32 157 € | 34 438 € |
Current Liabilities | 17 286 € | 19 614 € | 12 227 € | 13 662 € |
Non Current Liabilities | - | - | - | - |
Total Liabilities | - | - | - | - |
Share Capital | - | - | - | - |
Equity | 17 162 € | 19 003 € | 19 930 € | 20 776 € |
Employees | 2 | 3 | 4 | 5 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 15 835.21 € | 16 594.5 € | 6 |
2023 Q4 | - | 13 600.03 € | 14 274.88 € | 6 |
2023 Q3 | - | 17 724.97 € | 18 593.02 € | 5 |
2023 Q2 | - | 14 066.16 € | 14 766.53 € | 5 |
2023 Q1 | - | 14 554.3 € | 15 277.51 € | 5 |
2022 Q4 | - | 17 639.21 € | 18 481.18 € | 5 |
2022 Q3 | - | 17 416.95 € | 18 210.44 € | 5 |
2022 Q2 | - | 15 813.88 € | 16 534.35 € | 5 |
2022 Q1 | - | 14 257.82 € | 14 918.37 € | 6 |
2021 Q4 | - | 13 949.09 € | 14 699.56 € | 6 |
2021 Q3 | - | 13 714.79 € | 14 545.04 € | 6 |
2021 Q2 | - | 9 116.7 € | 9 637.92 € | 5 |
2021 Q1 | - | 11 191.35 € | 11 812.8 € | 4 |
2020 Q4 | - | 8 781.64 € | 9 254.32 € | 4 |
2020 Q3 | - | 9 632.5 € | 10 099.97 € | 4 |
2020 Q2 | - | 7 766.7 € | 8 138.7 € | 3 |
2020 Q1 | - | 7 536.63 € | 7 899.35 € | 3 |